Brief: Cytomed Therapeutics Enters Business & Research Collaboration Agreement With Sunact
06/01/2025 12:15
Jan 6 (Reuters) - CytoMed Therapeutics Ltd F98.F :
* CYTOMED THERAPEUTICS LTD - ENTERS BUSINESS & RESEARCH
COLLABORATION AGREEMENT WITH SUNACT
* CYTOMED THERAPEUTICS LTD - BRCA TERM IS FIVE YEARS
Source text: ID:nGNX5nXPps
Further company coverage: F98.F
((Reuters.Brief@thomsonreuters.com))
Recent news on CytoMed Therapeutics
See all newsBrief: Cytomed Therapeutics Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: CytoMed Therapeutics To Start Dose Level 2 In Angelica Trial Q3 2025
Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million